Ontology highlight
ABSTRACT: Objective
Osteoarthritis (OA) is the most common cause of disability in older adults, and leads to a huge unmet medical need, as no registered disease modifying OA drugs (DMOADs), but only symptomatic treatments, are available. New targets and compounds for these targets, are currently under investigation. The objective of this paper is to provide an overview of compounds under investigation for OA in phase II and III.Design
We performed a review of OA trials for pharmacological interventions registered on the National Library of Medicine ClinicalTrials.gov website with a completion date in 2017 or later.Results
The database search yielded 255 results, of which 184 studies were included in this review. These were structured in compounds targeting pain, immunomodulat
SUBMITTER: Vrouwe JPM
PROVIDER: S-EPMC9718290 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature